Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Calculators
Compare Best Stocks
Updated: Jul 16, 2026
Andreas Argyrides's Stock Ratings
Chardan Capital Analyst
Andreas Argyrides is an analyst at Chardan Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends.
Overall Average Return
18.4%
Smart Score
Overall Average Return Percentile
73rd
Number of Ratings
135
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 07/06/2026 | IRD | Buy Now | Opus Genetics | $3.40 | 282.92% | $13 → $13 | Maintains | Buy | Get Alert | |
| 07/01/2026 | EYPT | Buy Now | EyePoint | $13.86 | 368.98% | $29 → $65 | Maintains | Buy | Get Alert | |
| 06/18/2026 | IRD | Buy Now | Opus Genetics | $3.40 | 282.92% | $11 → $13 | Maintains | Buy | Get Alert | |
| 03/16/2026 | IRD | Buy Now | Opus Genetics | $3.40 | 194.55% | → $10 | Initiates | → Outperform | Get Alert | |
| 03/12/2026 | LQDA | Buy Now | Liquidia | $77.75 | -75.56% | $16 → $19 | Maintains | Underperform | Get Alert | |
| 03/05/2026 | GOSS | Buy Now | Gossamer Bio | $0.15 | 1877.59% | $12 → $3 | Maintains | Outperform | Get Alert | |
| 02/26/2026 | UTHR | Buy Now | United Therapeutics | $535.13 | 12.12% | $575 → $600 | Maintains | Outperform | Get Alert | |
| 02/24/2026 | MLTX | Buy Now | MoonLake | $19.68 | 77.85% | $30 → $35 | Maintains | Outperform | Get Alert | |
| 01/22/2026 | EVMN | Buy Now | Evommune | $12.18 | 244.83% | → $42 | Initiates | → Outperform | Get Alert | |
| 12/10/2025 | DYN | Buy Now | Dyne Therapeutics | $23.43 | 70.72% | $11 → $40 | Upgrade | Perform → Outperform | Get Alert | |
| 11/14/2025 | SVRA | Buy Now | Savara | $5.80 | 55.17% | $8 → $9 | Maintains | Outperform | Get Alert | |
| 11/12/2025 | KROS | Buy Now | Keros Therapeutics | $10.96 | 146.24% | $23 → $27 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/12/2025 | DYN | Buy Now | Dyne Therapeutics | $23.43 | -53.05% | $13 → $11 | Maintains | Perform | Get Alert | |
| 10/10/2025 | DYN | Buy Now | Dyne Therapeutics | $23.43 | -44.52% | $13 → $13 | Downgrade | Outperform → Perform | Get Alert | |
| 10/02/2025 | MNPR | Buy Now | Monopar Therapeutics | $108.99 | 5.51% | $77 → $115 | Maintains | Outperform | Get Alert | |
| 10/02/2025 | LRMR | Buy Now | Larimar Therapeutics | $3.73 | 462.25% | $26 → $21 | Maintains | Outperform | Get Alert | |
| 09/16/2025 | BNTC | Buy Now | Benitec Biopharma | $13.02 | 122.73% | $35 → $29 | Maintains | Outperform | Get Alert | |
| 09/11/2025 | KALA | Buy Now | Kala Bio | $0.96 | 3337.14% | $15 → $33 | Maintains | Outperform | Get Alert | |
| 09/08/2025 | SVRA | Buy Now | Savara | $5.80 | 37.93% | $6 → $8 | Maintains | Outperform | Get Alert | |
| 09/05/2025 | UTHR | Buy Now | United Therapeutics | $535.13 | 7.45% | $510 → $575 | Maintains | Outperform | Get Alert | |
| 09/05/2025 | MNKD | Buy Now | MannKind | $4.14 | 262.33% | $12 → $15 | Maintains | Outperform | Get Alert | |
| 09/03/2025 | MNPR | Buy Now | Monopar Therapeutics | $108.99 | -29.35% | → $77 | Initiates | → Outperform | Get Alert | |
| 08/15/2025 | ABEO | Buy Now | Abeona Therapeutics | $7.35 | 172.11% | $19 → $20 | Maintains | Outperform | Get Alert | |
| 08/06/2025 | DYN | Buy Now | Dyne Therapeutics | $23.43 | -44.52% | $34 → $13 | Maintains | Outperform | Get Alert | |
| 06/02/2025 | KALA | Buy Now | Kala Bio | $0.96 | 1462.34% | → $15 | Assumes | → Outperform | Get Alert | |
| 06/02/2025 | HRMY | Buy Now | Harmony Biosciences Hldgs | $33.33 | 83.02% | → $61 | Assumes | → Outperform | Get Alert | |
| 06/02/2025 | AQST | Buy Now | Aquestive Therapeutics | $3.91 | 79.03% | $15 → $7 | Assumes | → Outperform | Get Alert | |
| 06/02/2025 | ABEO | Buy Now | Abeona Therapeutics | $7.35 | 158.5% | → $19 | Assumes | → Outperform | Get Alert | |
| 06/02/2025 | DYN | Buy Now | Dyne Therapeutics | $23.43 | 45.11% | $60 → $34 | Assumes | → Outperform | Get Alert | |
| 05/29/2025 | IFRX | Buy Now | InflaRx | $2.05 | 46.34% | $6 → $3 | Maintains | Outperform | Get Alert | |
| 05/19/2025 | LQDA | Buy Now | Liquidia | $77.75 | -83.28% | → $13 | Downgrade | Perform → Underperform | Get Alert | |
| 05/16/2025 | RANI | Buy Now | Rani Therapeutics Hldgs | $0.65 | 512.46% | $14 → $4 | Maintains | Outperform | Get Alert | |
| 05/13/2025 | KRRO | Buy Now | Korro Bio | $12.70 | 608.94% | $155 → $90 | Maintains | Outperform | Get Alert | |
| 05/13/2025 | PRQR | Buy Now | ProQR Therapeutics | $1.71 | 426.32% | $15 → $9 | Maintains | Outperform | Get Alert | |
| 05/08/2025 | IFRX | Buy Now | InflaRx | $2.05 | 192.68% | → $6 | Initiates | → Outperform | Get Alert | |
| 01/17/2025 | KROS | Buy Now | Keros Therapeutics | $10.96 | 36.8% | $47 → $15 | Downgrade | Outperform → Neutral | Get Alert | |
| 01/16/2025 | KROS | Buy Now | Keros Therapeutics | $10.96 | 109.76% | $63 → $23 | Maintains | Outperform | Get Alert | |
| 12/16/2024 | KROS | Buy Now | Keros Therapeutics | $10.96 | 474.56% | $102 → $63 | Maintains | Outperform | Get Alert | |
| 11/15/2024 | ASND | Buy Now | Ascendis Pharma | $264.50 | -31.57% | $181 → $181 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/16/2024 | LRMR | Buy Now | Larimar Therapeutics | $3.73 | 596.12% | → $26 | Initiates | → Outperform | Get Alert | |
| 10/16/2024 | BNTC | Buy Now | Benitec Biopharma | $13.02 | 168.82% | → $35 | Initiates | → Outperform | Get Alert | |
| 08/14/2024 | RGLS | Buy Now | Regulus Therapeutics | — | — | $7 → $7 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/02/2024 | RANI | Buy Now | Rani Therapeutics Hldgs | $0.65 | 2502.97% | → $17 | Initiates | → Outperform | Get Alert | |
| 06/25/2024 | LQDA | Buy Now | Liquidia | $77.75 | — | — | Initiates | → Perform | Get Alert | |
| 06/25/2024 | MLTX | Buy Now | MoonLake | $19.68 | 428.46% | → $104 | Initiates | → Outperform | Get Alert | |
| 06/25/2024 | KROS | Buy Now | Keros Therapeutics | $10.96 | 830.23% | → $102 | Initiates | → Outperform | Get Alert | |
| 06/25/2024 | CLSD | Buy Now | Clearside Biomedical | — | — | → $5 | Initiates | → Outperform | Get Alert | |
| 06/25/2024 | GOSS | Buy Now | Gossamer Bio | $0.15 | 5832.76% | → $9 | Initiates | → Outperform | Get Alert | |
| 03/13/2024 | MLTX | Buy Now | MoonLake | $19.68 | 367.48% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/11/2024 | MLTX | Buy Now | MoonLake | $19.68 | 367.48% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/11/2024 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 151.32% | $19 → $19 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/07/2024 | AQST | Buy Now | Aquestive Therapeutics | $3.91 | 130.18% | $4 → $9 | Maintains | Outperform | Get Alert | |
| 03/06/2024 | OCS | Buy Now | Oculis Holding | $12.80 | 126.56% | $29 → $29 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/06/2024 | GOSS | Buy Now | Gossamer Bio | $0.15 | 3855.17% | $6 → $6 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/01/2024 | MLTX | Buy Now | MoonLake | $19.68 | 367.48% | $92 → $92 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/28/2024 | RGNX | Buy Now | Regenxbio | $11.75 | 78.72% | $21 → $21 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/20/2024 | SRPT | Buy Now | Sarepta Therapeutics | $17.43 | 1185.14% | $224 → $224 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/12/2024 | RGNX | Buy Now | Regenxbio | $11.75 | 78.72% | $21 → $21 | Reiterates | Neutral → Neutral | Get Alert | |
| 02/08/2024 | PCRX | Buy Now | Pacira BioSciences | $25.37 | 124.67% | $57 → $57 | Reiterates | Outperform → Outperform | Get Alert | |
| 02/08/2024 | ASND | Buy Now | Ascendis Pharma | $264.50 | -14.93% | $207 → $225 | Maintains | Outperform | Get Alert | |
| 02/06/2024 | RANI | Buy Now | Rani Therapeutics Hldgs | $0.65 | 1124.93% | $8 → $8 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/30/2024 | SRPT | Buy Now | Sarepta Therapeutics | $17.43 | 1185.14% | $224 → $224 | Reiterates | Outperform → Outperform | Get Alert | |
| 01/09/2024 | SRPT | Buy Now | Sarepta Therapeutics | $17.43 | 1185.14% | $224 → $224 | Reiterates | Outperform → Outperform | Get Alert | |
| 12/21/2023 | LQDA | Buy Now | Liquidia | $77.75 | -96.14% | $3 → $3 | Reiterates | Underperform → Underperform | Get Alert | |
| 12/20/2023 | ASND | Buy Now | Ascendis Pharma | $264.50 | -23.63% | $200 → $202 | Maintains | Outperform | Get Alert | |
| 12/01/2023 | MLTX | Buy Now | MoonLake | $19.68 | 367.48% | → $92 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/21/2023 | SRPT | Buy Now | Sarepta Therapeutics | $17.43 | 1185.14% | → $224 | Initiates | → Outperform | Get Alert | |
| 11/17/2023 | OCS | Buy Now | Oculis Holding | $12.80 | 126.56% | → $29 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/16/2023 | MLTX | Buy Now | MoonLake | $19.68 | 367.48% | $86 → $92 | Maintains | Outperform | Get Alert | |
| 11/16/2023 | UBX | Buy Now | Unity Biotechnology | — | — | — | Upgrade | Neutral → Outperform | Get Alert | |
| 11/13/2023 | KROS | Buy Now | Keros Therapeutics | $10.96 | 684.31% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/13/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 71.96% | $5 → $13 | Maintains | Outperform | Get Alert | |
| 11/10/2023 | GOSS | Buy Now | Gossamer Bio | $0.15 | 3855.17% | $5 → $6 | Maintains | Outperform | Get Alert | |
| 11/08/2023 | ASND | Buy Now | Ascendis Pharma | $264.50 | -27.41% | → $192 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/07/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/06/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/16/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/10/2023 | IMUX | Buy Now | Immunic | $15.03 | -53.43% | $5 → $7 | Maintains | Outperform | Get Alert | |
| 10/10/2023 | AQST | Buy Now | Aquestive Therapeutics | $3.91 | 2.3% | → $4 | Reiterates | Outperform → Outperform | Get Alert | |
| 10/10/2023 | MNKD | Buy Now | MannKind | $4.14 | 141.55% | → $10 | Initiates | → Outperform | Get Alert | |
| 10/05/2023 | RGNX | Buy Now | Regenxbio | $11.75 | 70.21% | → $20 | Reiterates | Neutral → Neutral | Get Alert | |
| 10/03/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/22/2023 | AQST | Buy Now | Aquestive Therapeutics | $3.91 | 2.3% | → $4 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/21/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | -33.86% | $15 → $5 | Maintains | Outperform | Get Alert | |
| 09/18/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 09/06/2023 | ASND | Buy Now | Ascendis Pharma | $264.50 | -27.41% | $187 → $192 | Maintains | Outperform | Get Alert | |
| 08/31/2023 | KROS | Buy Now | Keros Therapeutics | $10.96 | 684.31% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/17/2023 | RANI | Buy Now | Rani Therapeutics Hldgs | $0.65 | 2962.32% | → $20 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/14/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 98.41% | → $15 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/14/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/14/2023 | LQDA | Buy Now | Liquidia | $77.75 | -96.14% | → $3 | Reiterates | Underperform → Underperform | Get Alert | |
| 08/11/2023 | GOSS | Buy Now | Gossamer Bio | $0.15 | 3195.98% | → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/11/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 13413.51% | $16 → $10 | Maintains | Outperform | Get Alert | |
| 08/08/2023 | KROS | Buy Now | Keros Therapeutics | $10.96 | 684.31% | → $86 | Reiterates | Outperform → Outperform | Get Alert | |
| 08/01/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.38 | 17.88% | $73 → $70 | Maintains | Neutral | Get Alert | |
| 07/31/2023 | MLTX | Buy Now | MoonLake | $19.68 | 336.99% | $61 → $86 | Maintains | Outperform | Get Alert | |
| 07/31/2023 | KROS | Buy Now | Keros Therapeutics | $10.96 | 684.31% | → $86 | Initiates | → Outperform | Get Alert | |
| 07/27/2023 | IMUX | Buy Now | Immunic | $15.03 | -66.73% | → $5 | Reiterates | Outperform → Outperform | Get Alert | |
| 07/26/2023 | GOSS | Buy Now | Gossamer Bio | $0.15 | 3195.98% | $7 → $5 | Maintains | Outperform | Get Alert | |
| 07/21/2023 | GOSS | Buy Now | Gossamer Bio | $0.15 | 4514.37% | → $7 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/30/2023 | LQDA | Buy Now | Liquidia | $77.75 | -96.14% | → $3 | Reiterates | → Underperform | Get Alert | |
| 06/30/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.38 | 22.94% | $69 → $73 | Maintains | Neutral | Get Alert | |
| 06/26/2023 | UBX | Buy Now | Unity Biotechnology | — | — | $3 → $2 | Downgrade | Outperform → Neutral | Get Alert | |
| 06/21/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 98.41% | $17 → $15 | Maintains | Outperform | Get Alert | |
| 06/07/2023 | ASND | Buy Now | Ascendis Pharma | $264.50 | -29.3% | → $187 | Reiterates | Outperform → Outperform | Get Alert | |
| 06/02/2023 | ASND | Buy Now | Ascendis Pharma | $264.50 | -29.3% | $186 → $187 | Maintains | Outperform | Get Alert | |
| 05/18/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 124.87% | → $17 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/12/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 124.87% | → $17 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/10/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 124.87% | → $17 | Reiterates | → Outperform | Get Alert | |
| 05/09/2023 | LQDA | Buy Now | Liquidia | $77.75 | -96.14% | → $3 | Reiterates | → Underperform | Get Alert | |
| 05/08/2023 | ASND | Buy Now | Ascendis Pharma | $264.50 | -29.68% | $195 → $186 | Maintains | Outperform | Get Alert | |
| 04/28/2023 | OCS | Buy Now | Oculis Holding | $12.80 | 110.94% | → $27 | Initiates | → Outperform | Get Alert | |
| 04/27/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.38 | 16.2% | $74 → $69 | Maintains | Neutral | Get Alert | |
| 04/25/2023 | UBX | Buy Now | Unity Biotechnology | — | — | $5 → $3 | Maintains | Outperform | Get Alert | |
| 03/28/2023 | UBX | Buy Now | Unity Biotechnology | — | — | $35 → $5 | Maintains | Outperform | Get Alert | |
| 03/22/2023 | MLTX | Buy Now | MoonLake | $19.68 | 67.68% | → $33 | Initiates | → Outperform | Get Alert | |
| 03/20/2023 | LQDA | Buy Now | Liquidia | $77.75 | -96.14% | → $3 | Reiterates | → Underperform | Get Alert | |
| 03/16/2023 | UBX | Buy Now | Unity Biotechnology | — | — | → $35 | Reiterates | → Outperform | Get Alert | |
| 03/09/2023 | AQST | Buy Now | Aquestive Therapeutics | $3.91 | 2.3% | $3 → $4 | Upgrade | Neutral → Outperform | Get Alert | |
| 02/28/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.38 | 24.62% | $83 → $74 | Maintains | Neutral | Get Alert | |
| 02/27/2023 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 21521.62% | → $16 | Upgrade | Neutral → Outperform | Get Alert | |
| 01/31/2023 | PCRX | Buy Now | Pacira BioSciences | $25.37 | 136.5% | → $60 | Assumes | → Outperform | Get Alert | |
| 01/31/2023 | SPRY | Buy Now | ARS Pharmaceuticals | $7.56 | 32.28% | → $10 | Initiates | → Outperform | Get Alert | |
| 01/31/2023 | IMUX | Buy Now | Immunic | $15.03 | -66.73% | → $5 | Assumes | → Outperform | Get Alert | |
| 01/11/2023 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.38 | 39.78% | $74 → $83 | Maintains | Neutral | Get Alert | |
| 01/09/2023 | ALBO | Buy Now | Albireo Pharma | — | — | $53 → $42 | Downgrade | Outperform → Neutral | Get Alert | |
| 11/14/2022 | ASND | Buy Now | Ascendis Pharma | $264.50 | -38% | $151 → $164 | Maintains | Outperform | Get Alert | |
| 11/02/2022 | UBX | Buy Now | Unity Biotechnology | — | — | $4 → $36 | Maintains | Outperform | Get Alert | |
| 09/19/2022 | GOSS | Buy Now | Gossamer Bio | $0.15 | 15720.7% | → $24 | Initiates | → Outperform | Get Alert | |
| 08/16/2022 | ALBO | Buy Now | Albireo Pharma | — | — | $72 → $61 | Maintains | Outperform | Get Alert | |
| 08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | — | Downgrade | Outperform → Neutral | Get Alert | |
| 06/13/2022 | BMRN | Buy Now | Biomarin Pharmaceutical | $59.38 | 17.88% | → $70 | Assumes | → Neutral | Get Alert | |
| 06/13/2022 | SGMO | Buy Now | Sangamo Therapeutics | $0.07 | 6656.76% | → $5 | Assumes | → Neutral | Get Alert | |
| 06/13/2022 | RANI | Buy Now | Rani Therapeutics Hldgs | $0.65 | 4187.25% | → $28 | Initiates | → Outperform | Get Alert | |
| 12/15/2021 | RGNX | Buy Now | Regenxbio | $11.75 | 146.81% | → $29 | Initiates | → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investor Events
- Pre-market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2026 Benzinga | All Rights Reserved